Document is current
Any future updates will be listed below
-
Authors
Aragon-Gawinska, Karolina https://orcid.org/0000-0002-6447-6388
Nungo-Garzon, Nancy Carolina https://orcid.org/0000-0002-9272-895X
Muelas, Nuria https://orcid.org/0000-0002-2349-7481
Sivera, Rafael https://orcid.org/0000-0003-2810-1180
Sevilla, Teresa https://orcid.org/0000-0003-4716-2667
Hervas, David https://orcid.org/0000-0003-0635-4961
Pitarch-Castellano, Inmaculada https://orcid.org/0000-0002-3864-7374
Vazquez-Costa, Juan F. https://orcid.org/0000-0002-3043-7938
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI 24/01512)
Instituto de Salud Carlos III (DTS23/00112)
Instituto de Salud Carlos III (PI21/01532)
Instituto de Salud Carlos III (PI22/01830)
Conselleria de Cultura, Educación y Ciencia, Generalitat Valenciana (CIPROM/2023/053)
Universitat de Valencia
- License Information
-
More Information
Article History
Received: 22 April 2026
Revised: 15 June 2026
Accepted: 17 June 2026
First Online: 29 June 2026
Declarations
:
: KAG received lecture honoraria from Biogen and Amicus, conference and travel fees from Roche, Amicus, Italfarmaco, PTC Therapeutics. NCNG received conference and travel fees from Roche. IPC received lecture honoraria from Biogen, Roche, Novartis and Scholar Rock. NM, RS, TS, and DH report no conflict of interest related to the present work. JFVC is a member of the advisory board of CUIDAME and has received personal fees from Biogen, Roche, Novartis and Scholar Rock outside the submitted work.
: His study was approved by the Ethics Committee for Biomedical Research of La Fe Hospital (Valencia, Spain) 2019–027-1 and all participants provided informed consent.
